Artificial intelligent Clinical Evaluation (AiCE)
by L&T Technology Services
Artificial intelligent Clinical Evaluation (AiCE)
What is AiCE and its purpose?
Purpose:
The AiCE is an AI assistive tool that shall be used for the literature search and appraisal process.
Background:
The manual literature search and appraisal process is time-consuming and has opportunities for errors.
Use:
AiCE can save 30% of the time, without any compromise on the accuracy of the review process with quality.
Intent:
The intent of the AiCE tool is to simplify the literature search and appraisal process with AI Assist
AiCE Capabilities:
Search Protocol:
• Capable of handling data from PubMed and Google Scholar
• Search protocol can be created within AiCE
• Search can be customized for the subject device, state-of-the-art, and competitor device.
• Multiple projects can be created and managed at different access levels.
Screening
• Screening can be performed at two levels, abstract and full-text.
• Tool is capable of supporting researchers with relevancy prediction scoring.
• Tool can highlight all key attributes for screening, such as device name, procedure, patient details, study type etc.
Appraisal:
• AiCE can auto-populate pre-fixed essential attributes for appraisal activity.
• Capable of DAPR and TOFCS grading
• Side by side view is available to check attributes and articles at a time.
• Quality and Monitoring
• The manager will have real-time monitoring access for all the projects.
• At each stage of screening, articles can be reassigned and reviewed by QA.
• AiCE makes allocation and execution easier.
AiCE offers 3 Levels of Access Roles:
Manager:
• Able to plan, assign and track the articles across access levels.
• Create Projects
• Create Users
• Monitors progress
Research:
• Receives allocation from the manager.
• Access abstract and full text
• Able to screen, appraise and process the assigned articles.
Quality Analyst
• Receives allocation from the manager.
• Able to perform quality checks of screening and appraisal activities.